Hungary, as the first European country to legislate TCM, its legislation experience has significant implications for the international development of TCM. This article reviewed the historical process of TCM legislation in Hungary, summarized its legislative achievements, and analyzed the problems encountered during the implementation process. It was found that the current challenges faced by TCM legislation in Hungary mainly include constraints from the dominance of modern medicine, restrictions from strict qualification requirements, insufficient public awareness, difficulties in TCM registration, and challenges in policy coordination and cooperation. Based on these findings, the article proposed countermeasures such as improving the legal framework, strengthening educational cooperation, enhancing public awareness, promoting the mutual recognition of standards between China and Europe, and deepening China-Hungary collaboration. These measures aim to further improve the legislation and implementation of TCM in Hungary, thereby promoting the healthy development of TCM in Hungary and the global service trade of TCM.

Multiple sclerosis (MS) is a chronic central nervous system disease characterized by primary pathological inflammatory white matter demyelination in the central nervous system, the etiology is unclear and the disease can result in one of the main causes of non-traumatic young adults with disabilities, and regretfully, there are no effective ways to cure it radically. Western medicine often uses primarily corticosteroids and immunosuppressive agents for the treatment of this disease. However, using western medicine alone is not ideal to control the disease progress. For more than 10 years, the author has used the following traditional Chinese medicine (TCM) for treatment of this disease, the scheme of TCM is based on the western medicine's control of the acute phase, simultaneously using acupuncture, Chinese medicine, and correcting the patient's bad habits to treat MS, and we have obtained good therapeutic results, the neurological symptoms are significantly improved and the immune function regulated; in addition, the dosages of corticosteroids and immunosuppressants used can be decreased and further, the disease severity, incidences of recurrence and western drug side effects can be reduced and the disease progression can become milder or much milder or prevented, so as providing compensation to the deficits of western medicine.

Objective To explore the efficacy of endoscopic surgery for juvenile nasopharyngeal angiofibroma.MethodsDuring 27 years from March 1980 to July 2007,we performed endoscopic surgery on totally 19 patients with nasopharyngeal angiofibromas.According to Radkowski Stating,five of the patients were stage ⅠA,ten were stage ⅠB,and 4 were stage ⅡA.Before the endoscopy,superselective embolization was performed in all the cases via bilateral maxillary arteries.Results All tumors were successfully resected by endoscopy.The intraoperative blood loss was 200-600 ml.One of the stageⅡA patient developed cerebrospinal rhinorrhea during the endoscopic resection,and thus received repair of the middle turbinate by a mucosal patch immediately.In this series of patients,no massive epistaxis,intracerebral infection,or blindness occurred.Follow-up at three months after the surgery by nasoscopy showed epithelialisation of the nasal mucous membrane without residual tumor tissues.Meanwhile,otoscopy revealed normal light reflex of the eardrum,no fluid in the middle ear.Of the patients,eleven were followed up for one to five years,during which none of them had recurrent tumors confirmed by nasoscopy or CT scan.Conclusions Endoscopic resection of nasopharyngeal angiofibroma results in little trauma and few blood loss after superselective embolization.Experience and surgical skills are key points for the operation.